Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	25.26	24.57	39.88	45.28	27.35	22.06
Short-Term Investments	70.66	89.02	79.23	172.29	164.07	32.07
Cash & Short-Term Investments	95.91	113.59	119.11	217.57	191.41	54.13
Cash Growth	-24.91%	-4.63%	-45.26%	13.66%	253.61%	-26.12%
Receivables	4.68	8.92	0.3	0.48	0.62	0.77
Prepaid Expenses	-	3.44	9.45	13.5	13	2.59
Total Current Assets	100.59	125.95	128.86	231.55	205.03	57.49
Property, Plant & Equipment	3.24	3.85	5.48	3.78	4.77	5.78
Long-Term Investments	71.3	90.3	62.77	12.24	34.24	-
Other Intangible Assets	-	-	-	6.97	7.05	7.12
Other Long-Term Assets	0.41	0.22	0.3	0.05	0.12	0.39
Total Assets	175.53	220.33	197.41	254.6	251.21	70.78
Accounts Payable	9.19	4.69	8.88	10.35	9.99	5.25
Accrued Expenses	5.83	7.6	10.86	8.2	7.37	5.91
Current Portion of Leases	0.53	0.48	0.43	0.68	0.72	0.6
Current Unearned Revenue	3.93	3.89	-	-	-	-
Other Current Liabilities	6.16	14.94	10.79	2.7	4.85	3.11
Total Current Liabilities	25.63	31.6	30.95	21.94	22.93	14.87
Long-Term Debt	-	-	-	-	-	10.65
Long-Term Leases	1.71	2.12	3.07	1.57	2.17	2.89
Long-Term Unearned Revenue	17.49	20.04	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.37	0.37	0.37
Other Long-Term Liabilities	10.6	11.02	6.2	33.1	28.4	4.35
Total Liabilities	55.43	64.77	40.23	56.98	53.87	33.13
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	1,067	1,058	928.08	880.83	792.97	542.29
Retained Earnings	-947.99	-902.86	-770.8	-682.32	-595.41	-504.54
Comprehensive Income & Other	0.6	0.1	-0.11	-0.9	-0.22	-0.09
Total Common Equity	120.1	155.55	157.18	197.62	197.34	37.65
Shareholders' Equity	120.1	155.55	157.18	197.62	197.34	37.65
Total Liabilities & Equity	175.53	220.33	197.41	254.6	251.21	70.78
Total Debt	2.24	2.6	3.5	2.25	2.89	14.15
Net Cash (Debt)	164.97	201.3	178.38	227.56	222.76	39.98
Net Cash Growth	-3.37%	12.85%	-21.61%	2.15%	457.17%	-42.11%
Net Cash Per Share	1.43	2.60	2.56	3.49	3.93	0.94
Filing Date Shares Outstanding	108.35	107.92	70.93	66.69	61.28	51.8
Total Common Shares Outstanding	108.34	107.85	70.89	66.69	61.23	45.11
Working Capital	74.96	94.36	97.9	209.61	182.1	42.62
Book Value Per Share	1.11	1.44	2.22	2.96	3.22	0.83
Tangible Book Value	120.1	155.55	157.18	190.65	190.29	30.53
Tangible Book Value Per Share	1.11	1.44	2.22	2.86	3.11	0.68
Machinery	4.98	5	4.97	4.01	3.61	3.15
Leasehold Improvements	0.82	0.82	0.82	1.12	1.12	1.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.